EGFR and ulcerative colitis: The findings indicated that FS could modulate the progression of ulcerative colitis via multiple targets, with STAT3, EGFR, ESR1, PTGS2, NF-κB1 and JUN identified as the six key targets significantly involved in the pathogenesis and progression of ulcerative colitis.